The successful application of ICG-inhibitors (ICI) such as anti-CTLA-4 and anti-PD-1/PD-L1 in melanoma, lung cancer, and other cancers makes immunotherapy a feasible treatment for patients with advanced cancer [31]. This evidence concerns the gene CD274 and lung carcinoma.